Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Is The Type 2 Diabetes Market Expected To Grow In Terms Of Size?

The market for type 2 diabetes has seen robust growth in the last few years. The market size is projected to increase from $48.14 billion in 2024 to $51.47 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 6.9%. Factors such as changes in lifestyle and diet, an aging demographic, advancements in the pharmaceutical industry, and initiatives for public health have triggered the growth during the historic period.

We can anticipate robust growth in the type 2 diabetes market in the coming years. Predictions suggest it will expand to a valuation of $71.31 billion in 2029, growing at a compound annual growth rate (CAGR) of 8.5%. This projected growth within the forecasted period can be credited to the worldwide diabetes epidemic, the rise of personalized medicine, technological advancements, and modifications in healthcare policies. The future trends to look out for during this period are the surge in digital health and telemedicine, emphasis on prevention and early intervention, and the use of artificial intelligence (AI) and machine learning (ML) in healthcare, alongside metabolic surgery.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13050&type=smp

What Market Forces Are Contributing To The Growth Of The Type 2 Diabetes Market?

The predicted expansion of the type 2 diabetes market is fuelled by the rising occurrences of obesity and heart disease. Obesity, a health disorder characterized by an unhealthy excess of body fat, and heart disease, which refers to conditions impacting the heart and blood vessels, are instrumental in this growth. The accumulation of surplus body weight heightens the threat of insulin resistance, leading to increased blood sugar levels and the onset of type 2 diabetes. Conversely, elevated blood sugar levels can harm blood vessels and nerves that oversee the heart and blood vessels, contributing to heart disease. For example, the World Health Organization (WHO), an intergovernmental organization based in Switzerland, announced in March 2024 that roughly one out of every eight individuals globally was battling obesity. This included 2.5 billion adults of 18 years or older who were overweight, with 890 million among them suffering from obesity. Among adults, 43% were overweight, and 16% fell into the obesity category. Furthermore, the count of overweight children under the age of 5 came to 37 million. Consequently, the escalating numbers of obesity and heart disease cases are propelling the type 2 diabetes market’s growth.

How Is The Type 2 Diabetes Market Segmented Across Key Categories?

The type 2 diabetesmarket covered in this report is segmented –

1) By Drug Class: Dipeptidyl Peptidase-4 (DPP-4) Inhibitors; Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists; Thiazolidinediones; Alpha-Glucosidase Inhibitors; Sulfonylureas And Other Insulin Secretagogues; Biguanides; SodiumGlucose Cotransporter 2 Inhibitors; Other Drug Classes

2) By Application: Glycemic Control; Cardiovascular Safety; Hypoglycemia Avoidance; Other Applications

3) By End-User: Children; Adults

Subsegments:

1) By Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: Sitagliptin; Saxagliptin; Linagliptin; Alogliptin

2) By Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists: Liraglutide; Semaglutide; Dulaglutide; Exenatide

3) By Thiazolidinediones: Pioglitazone; Rosiglitazone

4) By Alpha-Glucosidase Inhibitors: Acarbose; Miglitol

5) By Sulfonylureas And Other Insulin Secretagogues: Glimepiride; Glipizide; Glyburide

6) By Biguanides: Metformin

7) By Sodium-Glucose Cotransporter 2 Inhibitors: Canagliflozin; Dapagliflozin; Empagliflozin

8) By Other Drug Classes: Amylin Analogues; Bile Acid Sequestrants; Dopamine Agonists

What Key Trends Are Driving Growth In The Type 2 Diabetes Market?

Innovative products like Mounjaro are being developed by major firms in the type 2 diabetes market, aiming to enhance safety and effectiveness standards for diabetics. Mounjaro and other innovative medications strive to improve diabetes management’s efficacy, safety, or convenience over current treatments. Emphasis is placed on boosting blood sugar control, reducing side effects, and addressing other health issues associated with diabetes in these drug advancement initiatives. For instance, Eli Lilly and Co., a United States pharmaceutical company, earned approval for Mounjaro (tripeptide) injection from the U.S. Food and Drug Administration in May 2022 to enhance blood sugar management in adults with type 2 diabetes, in addition to diet and exercise. Tirzepatide, a once-weekly injection that targets two blood sugar-regulating hormones, GLP-1 and glucose-dependent insulinotropic polypeptide (GIP), presents a novel, dual-targeted treatment approach for type 2 diabetes. While GLP-1 aims to boost insulin production and reduce glucagon production, GIP works to increase insulin production. Tirzepatide could potentially be a significant breakthrough for type 2 diabetics, even those who have found little success with other treatment avenues.

Who Are The Major Stakeholders Operating In The Type 2 Diabetes Market?

Major companies operating in the type 2 diabetes market are F. Hoffmann-La Roche AG, Merck and Co. Inc., Novartis AG, AstraZeneca PLC, Abbott Laboratories, Sanofi SA, Medtronic PLC, Takeda Pharmaceutical Company, GlaxoSmithKline plc., Eli Lilly and Company, Novo Nordisk A/S, Johnson And Johnson Private Limited, Daiichi Sankyo Co. Ltd., Boehringer Ingelheim International GmbH, Dexcom Inc., Amgen Inc., Insulet Corporation, Ascensia Diabetes Care, Byram Healthcare, Beta Bionics, Onduo LLC, DarioHealth, One Drop, Bigfoot Biomedical Inc., Digbi Health, MySugr GmbH, Senseonics Holdings Inc., Provention Bio Inc., Vida Health Inc., Diathrive Health.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/type-2-diabetes-global-market-report

How Do Regional Dynamics Influence The Type 2 Diabetes Market Performance?

North America was the largest region in the type 2 diabetes market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in type 2 diabetes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=13050&type=smp

Browse Through More Reports Similar to the Global Type 2 Diabetes Market 2025, By The Business Research Company

Digital Diabetes Management Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/digital-diabetes-management-global-market-report

Diabetes Care Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-global-market-report

Pet Diabetes Care Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model